Alessandro Rizzo
- Oncology top 0.5%
- Pulmonary and Respiratory Medicine top 0.5%
- Surgery top 1%
- Molecular Biology top 5%
- Cancer Research top 1%
- Co-authors
- Giovanni BrandiAngela Dalia RicciVeronica MollicaFrancesco MassariMatteo SantoniMatteo RoselliniAndrea MarchettiDeniz Can Güven
- Topics
- Cancer Immunotherapy and Biomarkers (68 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (56 papers)Renal cell carcinoma treatment (33 papers)
- Cited by
- OncologyHepatologyCancer Research
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- ItalyUnited StatesTürkiye
In The Last Decade
Alessandro Rizzo
211 papers receiving 6.5k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Oncology 3.3k
- Pulmonary and Respiratory Medicine 2.6k
- Surgery 2.0k
- Molecular Biology 1.6k
- Cancer Research 1.3k
Countries citing papers authored by Alessandro Rizzo
This map shows the geographic impact of Alessandro Rizzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Rizzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Rizzo more than expected).
Fields of papers citing papers by Alessandro Rizzo
This network shows the impact of papers produced by Alessandro Rizzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Rizzo. The network helps show where Alessandro Rizzo may publish in the future.
Co-authorship network of co-authors of Alessandro Rizzo
This figure shows the co-authorship network connecting the top 25 collaborators of Alessandro Rizzo. A scholar is included among the top collaborators of Alessandro Rizzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandro Rizzo. Alessandro Rizzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 7 | |
| 4 | 1 | |
| 5 | Prognostic Value of Neutrophil-to-Eosinophil Ratio (NER) in Cancer: A Systematic Review and Meta-Analysisbreakdown → | 65 |
| 6 | 4 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 5 | |
| 10 | 10 | |
| 11 | 11 | |
| 12 | 9 | |
| 13 | 72 | |
| 14 | 5 | |
| 15 | 4 | |
| 16 | 18 | |
| 17 | 37 | |
| 18 | 13 | |
| 19 | 46 | |
| 20 | 67 |
About Alessandro Rizzo
Alessandro Rizzo is a scholar working on Oncology, Hepatology and Pulmonary and Respiratory Medicine, having authored 220 papers that have together received 6.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (68 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (56 papers) and Renal cell carcinoma treatment (33 papers). The work is most often cited by research in Oncology (3.3k citations), Hepatology (770 citations) and Cancer Research (1.3k citations). Alessandro Rizzo has collaborated with scholars based in Italy, United States and Türkiye. Frequent co-authors include Giovanni Brandi, Angela Dalia Ricci, Veronica Mollica, Francesco Massari, Matteo Santoni, Matteo Rosellini, Andrea Marchetti, Deniz Can Güven, Simona Tavolari and Alessandro Di Federico. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.